Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer

BACKGROUND: Most cervical cancer patients with pelvic recurrent or persistent disease are not candidates for exenteration, therefore, they only receive palliative chemotherapy. Here we report the results of a novel treatment modality for these patients pre-exenterative chemotherapy- under the ration...

Descripción completa

Detalles Bibliográficos
Autores principales: Lopez-Graniel, Carlos, Dolores, Rigoberto, Cetina, Lucely, Gonzalez, Aaron, Cantu, David, Chanona, Jose, Uribe, Jesus, Candelaria, Myrna, Brom, Rocio, de la Garza, Jaime, Duenas-Gonzalez, Alfonso
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1260014/
https://www.ncbi.nlm.nih.gov/pubmed/16171526
http://dx.doi.org/10.1186/1471-2407-5-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1260014/
https://www.ncbi.nlm.nih.gov/pubmed/16171526
http://dx.doi.org/10.1186/1471-2407-5-118

Ejemplares similares